Jupiter Topco LLC Purchases New Stake in Inspire Medical Systems, Inc. $INSP

Jupiter Topco LLC bought a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 13,451 shares of the company’s stock, valued at approximately $601,000.

Other large investors have also added to or reduced their stakes in the company. ADAR1 Capital Management LLC bought a new stake in Inspire Medical Systems during the 2nd quarter worth approximately $16,712,000. Hsbc Holdings PLC bought a new position in shares of Inspire Medical Systems in the second quarter valued at approximately $274,000. Canada Pension Plan Investment Board bought a new position in shares of Inspire Medical Systems in the second quarter valued at approximately $7,365,000. Legal & General Group Plc bought a new position in shares of Inspire Medical Systems in the second quarter valued at approximately $2,732,000. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of Inspire Medical Systems during the second quarter valued at approximately $916,000. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Trading Down 0.1%

Shares of INSP stock opened at $62.99 on Monday. The firm’s 50 day moving average is $55.05 and its 200 day moving average is $52.38. The stock has a market capitalization of $1.82 billion, a P/E ratio of 13.63, a PEG ratio of 4.79 and a beta of 0.70. Inspire Medical Systems, Inc. has a 12 month low of $38.91 and a 12 month high of $147.03.

Inspire Medical Systems (NYSE:INSP) last issued its earnings results on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.38. The business had revenue of $200.58 million for the quarter, compared to analysts’ expectations of $194.72 million. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The business’s revenue for the quarter was down 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.45 EPS. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, equities analysts predict that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Freedom Capital upgraded shares of Inspire Medical Systems to a “strong-buy” rating in a report on Tuesday, June 30th. Zacks Research raised shares of Inspire Medical Systems from a “hold” rating to a “strong-buy” rating in a research report on Monday, August 17th. Summit Redstone set a $39.00 target price on Inspire Medical Systems in a report on Friday, May 22nd. Stifel Nicolaus set a $75.00 price target on Inspire Medical Systems in a research report on Tuesday, August 4th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $66.19.

Insider Buying and Selling

In other Inspire Medical Systems news, insider Jason Kelly sold 963 shares of Inspire Medical Systems stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the completion of the transaction, the insider owned 18,985 shares of the company’s stock, valued at $1,130,556.75. The trade was a 4.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 2.20% of the stock is currently owned by corporate insiders.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.